Takeshi Nishikawa
Overview
Explore the profile of Takeshi Nishikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
277
Citations
3414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamashita A, Kaku M, Ideguchi T, Nishida S, Kinoshita H, Nishikawa T
Endocr J
. 2025 Feb;
PMID: 39909435
In Japan, the guidelines for gestational weight gain (GWG) were revised in 2021. Under the new guidelines, pregnant women are recommended to increase their GWG. The aim of this study...
2.
Htun T, Elattar A, Elbohy H, Tsutsumi K, Horigane K, Nakano C, et al.
RSC Adv
. 2024 Jul;
14(32):23177-23183.
PMID: 39045399
Perovskite based on cesium bismuth bromide offers a compelling, non-toxic alternative to lead-containing counterparts in optoelectronic applications. However, its widespread usage is hindered by its wide bandgap. This study investigates...
3.
Tanaka Y, Hino H, Shiomi A, Uehara K, Watanabe J, Nishikawa T, et al.
Ann Gastroenterol Surg
. 2024 Jul;
8(4):631-638.
PMID: 38957561
Background: This study aimed to evaluate the efficacy of lateral lymph node dissection (LLND) for rectal cancer by comparing the local control in patients with and without pathological lateral lymph...
4.
Hosokawa S, Norimatsu Y, Shinagawa A, Kurokawa T, Yoshida Y, Nishikawa T, et al.
PLoS One
. 2024 May;
19(5):e0304420.
PMID: 38805498
Introduction: This study aimed to assess the localization of chondroitin sulfate (CS), a primary extracellular matrix component, in the stromal region of endometrial carcinoma (EC). Methods: Immunostaining was performed on...
5.
Suzuki H, Kondo Y, Oda C, Nishikawa T, Takeuchi M, Tatsumi S, et al.
J Cytol
. 2024 May;
41(2):116-122.
PMID: 38779606
Aims: The present study aimed to investigate whether the presence of mitoses in hyperchromatic crowded groups (HCGs) in cervical cytological specimens can serve as cytological criteria for high-grade squamous intra-epithelial...
6.
Hosokawa S, Yoshiaki N, Nishikawa T, Suzuki H, Kurokawa T, Shinagawa A, et al.
J Cytol
. 2024 May;
41(2):110-115.
PMID: 38779603
Background And Objective: In endometrial cytology, differentiating endometrial glandular stromal breakdown (EGBD) from endometrial endometrioid carcinoma (G1-EEC) is often difficult. In this study, we provided a new focus on chondroitin...
7.
Suzuki H, Kametaka J, Nakahori S, Tanaka Y, Iwahara M, Lin H, et al.
Small Methods
. 2024 Mar;
8(8):e2301387.
PMID: 38470210
The application of carbon nanotube (CNT) yarns as thermoelectric materials for harvesting energy from low-grade waste heat including that generated by the human body, is attracting considerable attention. However, the...
8.
Nishikawa T, Taira T, Kakizawa N, Ohno R, Nagasaki T
Oncol Lett
. 2024 Jan;
27(3):91.
PMID: 38268777
Sarcopenia is a prognostic factor for patients with colorectal cancer and is commonly seen in elderly patients. The purpose of the present study was to demonstrate the impact of preoperative...
9.
Nitta Y, Fujii T, Uchiyama T, Sugimoto A, Nishikawa T, Takeda M, et al.
Biomedicines
. 2023 Nov;
11(11).
PMID: 38002064
SRY-box transcription factor 9 (SOX9) is important for sexual differentiation, chondrogenic differentiation, and cell proliferation in cancer. It acts as a target molecule of microRNA (miR)-138 in various tumors and...
10.
Sawabata N, Morita K, Tatsumi S, Fujii T, Nishikawa T, Kawaguchi T, et al.
Anticancer Res
. 2023 Sep;
43(10):4683-4690.
PMID: 37772545
Background/aim: Circulating tumor cells (CTCs) have garnered attention as biomarkers for therapeutic response and prognosis in malignant neoplasms. Nonetheless, existing literature predominantly relies on surrogate markers of tumor cells or...